Intact Investment Management Inc. Boosts Stock Holdings in Colgate-Palmolive (NYSE:CL)

Intact Investment Management Inc. raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 121.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 32,500 shares of the company’s stock after acquiring an additional 17,800 shares during the period. Intact Investment Management Inc.’s holdings in Colgate-Palmolive were worth $2,591,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Vest Financial LLC raised its stake in Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after buying an additional 74,337 shares in the last quarter. Central Bank & Trust Co. raised its stake in Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC raised its stake in Colgate-Palmolive by 9.2% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares in the last quarter. Sarasin & Partners LLP raised its stake in Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after buying an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC raised its stake in Colgate-Palmolive by 2.5% in the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $85.35, for a total value of $762,175.50. Following the sale, the executive vice president now directly owns 8,043 shares in the company, valued at approximately $686,470.05. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $85.35, for a total value of $762,175.50. Following the sale, the executive vice president now directly owns 8,043 shares in the company, valued at approximately $686,470.05. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now owns 286,881 shares in the company, valued at $24,161,117.82. The disclosure for this sale can be found here. In the last quarter, insiders have sold 232,371 shares of company stock worth $19,505,099. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Performance

CL stock traded up $1.72 on Friday, hitting $91.01. The company had a trading volume of 7,541,541 shares, compared to its average volume of 3,968,951. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $92.25. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The stock’s 50-day simple moving average is $87.66 and its 200 day simple moving average is $81.54. The stock has a market cap of $74.81 billion, a price-to-earnings ratio of 28.80, a P/E/G ratio of 3.42 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 EPS. As a group, equities research analysts expect that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. Colgate-Palmolive’s payout ratio is 63.29%.

Analyst Ratings Changes

A number of research firms recently issued reports on CL. Evercore ISI increased their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Barclays raised their target price on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a research note on Friday, April 12th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Finally, JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.